Paper Review Records
All Paper Review Records
5 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
445
days
Tarloxotinib targets tumor hypoxia to improve therapeutic efficacy of immune checkpoint inhibition in a MyD88-dependent manner
Authors
Zhe Fu; Victoria Jackson-Patel; Kathryn Farrand; Alisha R Dabb; Xiaojing Lin; Emily Liu; Amir Ashoorzadeh; Jeff B Smaill; Ian F Hermans; Adam V PattersonShow moreShow less
Affiliations
1. Malaghan Institute of Medical Research, Wellington, New Zealand; 2. Auckland Cancer Society Research Centre, The University of Auckland, Auckland, New ZealandShow moreShow less
113
days
Neutrophil–epithelial niches arrest B-cell maturation in dysfunctional tertiary lymphoid structures of gastric cancer neoadjuvant immunochemotherapy
Authors
Chen Wei; Qiang Fu; Hejia Wei; Hao Zhai; Shuailei Dong; Xiaoqing Ma; Liangyu Bie; Yijie Ma; Yuanyuan Wang; Qingxin Xia; Suxia Luo; Ning LiShow moreShow less
Affiliations
1. Department of Internal Medicine, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, China; 2. Department of General Surgery, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, China; 3. School of First Clinical College, Shenyang Medical College, Shenyang, Liaoning, China; 4. Department of Pathology, The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, Henan, ChinaShow moreShow less
89
days
Engineering T cell-engaging bispecific antibodies targeting KRAS G12V neoantigen across HLA-A*11:01 and HLA-A*03:01
Authors
Xiaojing Wu; Clara Effenberger; Yosuke Matsushita; Hiroki Tanaka; Yu Ishii; Suyong Re; Saki Matsumoto; Satoshi Nagayama; Yusuke Nakamura; Kazuma KiyotaniShow moreShow less
Affiliations
1. Laboratory of Immunogenomics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki, Osaka, Japan; 2. Project for Immunogenomics, Cancer Precision Medicine Center, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, Japan; 3. Laboratory of Biofunctional Molecular Medicine, Center for Drug Design Research (CDDR), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki, Osaka, Japan; 4. Laboratory of Molecular Diagnostics and Therapeutics, Center for Intractable Diseases and ImmunoGenomics (CiDIG), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki, Osaka, Japan; 5. Laboratory of In Silico Design, Artificial Intelligence Center for Health and Biomedical Research (ArCHER), National Institutes of Biomedical Innovation, Health and Nutrition (NIBN), Ibaraki, Osaka, Japan; 6. Department of Surgery, Uji-Tokushukai Medical Center, Uji, Kyoto, Japan; 7. Department of Gastroenterological Surgery, Cancer Institute Hospital, Japanese Foundation for Cancer Research, Koto-ku, Tokyo, JapanShow moreShow less
140
days
Distinct genomic landscapes of mismatch-repair deficiency (dMMR)/microsatellite instability-high (MSI-H) gastrointestinal (GI) cancer depending on tumor mutation burden (TMB) levels
Authors
Jingyuan Wang; Joanne Xiu; Alex P Farrell; Francesca Battaglin; Hiroyuki Arai; Yan Yang; Shivani Soni; Wu Zhang; Joshua Millstein; Anthony F Shields; Axel Grothey; Benjamin A Weinberg; John Marshall; Emil Lou; Moh’d Khushman; Davendra P S Sohal; Michael J Hall; Tianshu Liu; Matthew James Oberley; David Spetzler; Heinz-Josef LenzShow moreShow less
Affiliations
1. Department of Medical Oncology, Cancer Center, Zhongshan Hospital Fudan University, Shanghai, China; 2. Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA; 3. Department of Oncology, Zhongshan Hospital (Xiamen), Fudan University, Xiamen, China. Clinical Research Center for Precision Medicine of Abdominal Tumor of Fujian Province, Xiamen, Fujian; 4. Caris Life Sciences, Phoenix, Arizona, USA; 5. Department of Preventive Medicine, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California, USA; 6. Department of Oncology, Karmanos Cancer Institute, Wayne State University, Detroit, Michigan, USA; 7. Gastrointestinal Cancer Research, West Cancer Center and Research Institute, Germantown, Tennessee, USA; 8. Ruesch Center for The Cure of Gastrointestinal Cancers, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, District of Columbia, USA; 9. Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, Minnesota, USA; 10. Departments of Medical Oncology, Washington University in St. Louis/Siteman Cancer Center, St. Louis, Missouri, USA; 11. University of Cincinnati, Cincinnati, Ohio, USA; 12. Department of Clinical Genetics, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USAShow moreShow less
245
days
Selective expansion of neoantigen-specific peripheral blood lymphocytes through antigen-presenting cell-T cell conjugate isolation
Authors
Mamduh Khateb; Raina Jung; Patrick Hadley; Stav Leibou; Zhiya Yu; Aaron J Dinerman; Victoria Dulemba; Billel Gasmi; Noam Levin; Sanghyun Peter Kim; Aarushi Bhasin; Deepali Bhat; Sivasish Sindiri; Jared J Gartner; Todd D Prickett; Tiffany Benzine; Shahram Farid; Maria Parkhurst; Hyunmi Halas; Guangzhe Ge; Yaqiang Cao; Keji Zhao; James C Yang; Paul Robbins; Frank J Lowery; Sri Krishna; Theo Heller; Daniel Mcvicar; Steven A Rosenberg; Nicholas D KlemenShow moreShow less
Affiliations
1. Surgery Branch, NCI, Bethesda, Maryland, USA; 2. Systems Biology Center, NHLBI, Bethesda, Maryland, USA; 3. NIDDK, Bethesda, Maryland, USA; 4. NCI/CCR, Bethesda, Maryland, USAShow moreShow less
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
Client
I work in environmental engineering and need an SCI paper published within three months. I have no grant funding or prominent co-author. Which journals could I target?
CrushSCI
Yes. We will first screen for feasibility against the 90-day deadline, then identify comparable papers without grant support or prominent co-authors. The final shortlist will prioritize research quality and journal scope.
- Suggested title
- Machine Learning and Life-Cycle Assessment for Predicting and Optimizing Carbon Emissions in Urban Wastewater Treatment
- Database shortlist
- Environmental Technology & Innovation
SampleLatest 5 valid paper samples from 2026
Average review62 days
Median65 days